Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis

John C. Feemster, Sarah M. Westerland, Thomas R. Gossard, Tyler A. Steele, Paul C. Timm, Jack T. Jagielski, Emma Strainis, Stuart J. McCarter, Seth C. Hopkins, Kenneth S. Koblan, Erik K. St. Louis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences